Form 4: CEO David E. Lazar Increases Stake in Quantum Cyber N.V.

CEO David E. Lazar acquired 2,000,000 additional preferred shares in Quantum Cyber N.V. following shareholder approval of key corporate actions.

Summary

• CEO David E. Lazar acquired 1,000,000 Series D Preferred Shares and 1,000,000 Series E Preferred Shares.
• The acquisition follows the receipt of shareholder approval on April 22, 2026.
• The total purchase price for these additional shares was $3,000,000 at $1.50 per share.
• Shareholder approval authorized an increase in ordinary shares to 900,000,000 and the conversion of preferred shares into ordinary shares.
• Each Series D and Series E Preferred Share is now convertible into 225 ordinary shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event for liquidity, but potentially negative for existing shareholders due to the significant dilution associated with the conversion of preferred shares.

Positives

• Significant capital injection of $3,000,000 from the CEO, demonstrating strong commitment to the company.
• Successful receipt of shareholder approval for key strategic initiatives, including share authorization and conversion terms.

Negatives

• High potential for significant shareholder dilution due to the conversion of preferred shares into a large number of ordinary shares.

Risks

• Dilution risk for existing shareholders as preferred shares convert into a substantial number of ordinary shares.
• Concentration of ownership and control in the hands of the CEO and his designees.

Future Outlook

The company is moving forward with a capital structure reorganization, including a reverse stock split and the conversion of preferred shares into ordinary shares, following the April 22, 2026 shareholder approval.

Management Comments

• The Reporting Person acquired the Second Closing Shares at a price of $1.50 per share following the receipt of Stockholder Approval.

Industry Context

StockSavvy.ai notes that this transaction reflects a common pattern in micro-cap companies where insiders provide necessary liquidity in exchange for significant equity stakes and control, often leading to substantial changes in capital structure.

Comparison to Industry Standards

• The use of preferred shares with high conversion ratios is a common mechanism in distressed or growth-stage biotech and tech firms to secure funding while maintaining control.
• The conversion of preferred shares into a large block of common equity is consistent with aggressive recapitalization strategies seen in the Nasdaq Capital Market.

Management Changes

Corporate Governance

Related Party Transactions

• The transaction is a direct purchase of securities by the CEO, David E. Lazar, from the Company.

Stakeholder Impact

• Existing shareholders face significant dilution.
• The company gains $3,000,000 in capital to support operations.
• The CEO gains increased control over corporate governance.

Next Steps

• Execution of the reverse stock split.
• Conversion of preferred shares into ordinary shares.
• Integration of the Reporting Person and his designees into the Board of Directors.

Key Dates

Recommendation

While the capital injection is positive for the company's balance sheet, the massive potential dilution from the conversion of preferred shares warrants a cautious 'hold' until the impact of the reverse stock split and the new board's strategy is clarified.

Keywords

Quantum Cyber, MYNZ, David E. Lazar, Insider Transaction, Preferred Shares, Shareholder Approval, Dilution